Clinical Trials

Text Size A A

E-Mail to a Friend






secret  Click to Play Audio


MultiCare Regional Cancer Center

Below are some of the SCCA clinical trials now being offered for patients at MultiCare Regional Cancer Center. If you have any questions about these or other trials, please contact MultiCare Regional Cancer Center.

Breast Cancer (Newly Diagnosed)

Breast Cancer (Recurrent/Metastatic)

  • Triple Negative (6628)
    Combined Targeted Therapies for Triple Negative Advanced Breast Cancer - A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib

Gynecologic Cancer (Newly Diagnosed)

Gynecologic Cancer (Recurrent/Metastatic)

Leukemia (Newly Diagnosed)

  • Vorinostat + Chemotherapy for CLL or SLL (PSOC-2401)
    A Phase I/II Study of Fludarabine (F), Cyclophosphamide ©), Rituximab ®), and Vorinostat (V) Followed by RV Maintenance Therapy in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small LymphoCtic Lymphoma (SLL)

Lymphoma (Newly Diagnosed)

  • Vorinostat + Chemotherapy for CLL or SLL (PSOC-2401)
    A Phase I/II Study of Fludarabine (F), Cyclophosphamide ©), Rituximab ®), and Vorinostat (V) Followed by RV Maintenance Therapy in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphoctic Lymphoma (SLL)

Lymphoma (Recurrent/Metastatic)